Freenome Inc. (FRNM)
FRNM trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.64
-4.39% on the day
Market cap
$1.4B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | FRNM on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0002017526 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-08-27 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-07-15 |
| Latest current report | 8-K/A | 2026-08-13 |
| Latest proxy DEF14A | DEF 14A | 2026-05-14 |
Source: SEC EDGAR submissions feed, 132 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -22.5% |
| 1 month | -15.1% |
| 3 months | +3.5% |
| Year to date | -4.6% |
| 1 year | +16.8% |
| From 52-week high | -27.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRUP | Trupanion Inc. | $26.57 | +1.06% | $1.2B |
| PSNL | Personalis Inc. | $15.85 | +0.32% | $1.7B |
| ALHC | Alignment Healthcare Inc. | $8.30 | +2.60% | $1.7B |
| LMRI | Lumexa Imaging Holdings Inc. | $10.61 | -0.66% | $1.0B |
| CSTL | Castle Biosciences Inc. | $32.88 | +0.37% | $1.0B |
| FTRE | Fortrea Holdings Inc. | $20.92 | -0.38% | $2.0B |
| CLOV | Clover Health Investments Corp. | $4.81 | +0.63% | $2.6B |
| ACHC | Acadia Healthcare Company Inc. | $30.23 | +0.50% | $2.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier